Prostatype Genomics AB (publ) (STO:PROGEN)
Sweden · Delayed Price · Currency is SEK 0.1000
-0.0040 (-3.85%)
Oct 19, 2026, 5:23 PM CET
Prostatype Genomics AB Market Cap
Prostatype Genomics AB has a market cap or net worth of 69.13 million as of October 19, 2026. It is the 43,289th most valuable company in the world and the 643rd biggest in Sweden. Its market cap has increased by 56.57% in one year.
Market Cap
69.13M
Enterprise Value
68.74M
Revenue
805.00K
Global Rank
Country Rank
#643 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since November 3, 2020, Prostatype Genomics AB's market cap has decreased from 92.30M to 69.13M, a decrease of -25.10%. That is a compound annual growth rate of -4.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 69.13M | 289.33% |
| Dec 30, 2025 | 17.76M | -76.14% |
| Dec 30, 2024 | 74.42M | 555.78% |
| Dec 29, 2023 | 11.35M | -76.58% |
| Dec 30, 2022 | 48.46M | -64.07% |
| Dec 30, 2021 | 134.89M | -28.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 152.15B |
| Getinge AB | 70.93B |
| Sectra AB | 61.62B |
| Medicover AB | 40.05B |
| Enorama Pharma AB | 73.99M |
| Ascelia Pharma AB | 71.44M |
| Annexin Pharmaceuticals AB | 70.97M |
| Pila Pharma AB | 69.44M |